Scibase AB (SCIB) - Total Liabilities

Latest as of December 2025: Skr45.51 Million SEK ≈ $4.90 Million USD

Based on the latest financial reports, Scibase AB (SCIB) has total liabilities worth Skr45.51 Million SEK (≈ $4.90 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Scibase AB - Total Liabilities Trend (2012–2025)

This chart illustrates how Scibase AB's total liabilities have evolved over time, based on quarterly financial data. See SCIB current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Scibase AB Competitors by Total Liabilities

The table below lists competitors of Scibase AB ranked by their total liabilities.

Company	Country	Total Liabilities
Hwail Pharmaceutical Co.Ltd KQ:061250	Korea	₩5.29 Billion
Orange County Bancorp Inc NASDAQ:OBT	USA	$2.38 Billion
Banco de Valores SA BA:VALO	Argentina	AR$2.14 Trillion
Petpal Pet Nutrition Technology Co Ltd SHE:300673	China	CN¥987.01 Million
GULF KEYSTONE PETR. F:GVP1	Germany	€149.70 Million
Hua Eng Wire & Cable Co Ltd TW:1608	Taiwan	NT$5.58 Billion
Cabaletta Bio Inc NASDAQ:CABA	USA	$44.84 Million
Everbright Jiabao Co Ltd SHG:600622	China	CN¥16.59 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Scibase AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Scibase AB worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.92	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.91	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	6.84	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.87	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Scibase AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Scibase AB (2012–2025)

The table below shows the annual total liabilities of Scibase AB from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr45.51 Million ≈ $4.90 Million	+81.46%
2024-12-31	Skr25.08 Million ≈ $2.70 Million	+17.87%
2023-12-31	Skr21.28 Million ≈ $2.29 Million	-13.56%
2022-12-31	Skr24.62 Million ≈ $2.65 Million	+67.92%
2021-12-31	Skr14.66 Million ≈ $1.58 Million	+18.31%
2020-12-31	Skr12.39 Million ≈ $1.33 Million	-12.42%
2019-12-31	Skr14.15 Million ≈ $1.52 Million	+46.84%
2018-12-31	Skr9.63 Million ≈ $1.04 Million	-20.95%
2017-12-31	Skr12.19 Million ≈ $1.31 Million	-114.63%
2016-12-31	Skr-83.30 Million ≈ $-8.96 Million	-39.71%
2015-12-31	Skr-138.17 Million ≈ $-14.87 Million	-1641.01%
2014-12-31	Skr8.97 Million ≈ $964.88K	+19.58%
2013-12-31	Skr7.50 Million ≈ $806.90K	-84.23%
2012-12-31	Skr47.56 Million ≈ $5.12 Million	--

About Scibase AB

ST:SCIB Sweden Medical Devices

Market Cap

$3.94 Billion

Skr36.61 Billion SEK

Market Cap Rank

#12819 Global

#199 in Sweden

Share Price

Skr35.80

Change (1 day)

-15.47%

52-Week Range

Skr0.21 - Skr50.80

All Time High

Skr50.80